ФАРМАКОЛОГИЯ ВЗАИМОДЕЙСТВИЯ РЕГУЛЯТОРНЫХ ПЕПТИДНЫХ СИСТЕМ ГОЛОВНОГО МОЗГА В МЕХАНИЗМАХ ПОДКРЕПЛЕНИЯ
Шрифт:
Naleid, A.M. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. /Naleid, A.M., Grace, M.K., Cummings, D.E., Levine, A.S. // Peptides 26 (11) – 2005 – Р.2274–2279.
Nambu, T. Distribution of orexin neurons in the adult rat brain. /T. Nambu, T. Sakurai, K. Mizukami et al. // Brain Res. – 1999 – Vol.827. – P.243–260.
Napier T.C. Opiod modulation of ventral pallidal inputs. /Napier T.C., Mitrovic I. // Ann. N.Y. Acad. Sci. 1999. V.87. P.176–201.
Nemeroff C.B. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. /Nemeroff C.B. // Neuropsychopharmacology. 1992. V. 6. P.69–75.
Nestler E.J. Is there a common molecular pathway for addiction? /Nestler E.J. // Nat Neurosci 2005;8:1445–1449.
Nicola S.M. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. /Nicola S.M., Surmeier J., Malenka R.C. // Annu. Rev. Neurosci. 2000. V.23. P.185–215.
Nijsen M.J. The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. /Nijsen M.J., Croiset G., Stam R. et al. // Neuropsychopharmacology. 2000. V. 22. P.388–399.
O’Donnell P. Dopamine gating of forebrain neural ensembles. /O’Donnell P. // Eur. J. Neurosci. 2003. V.17. P.429–435.
Okuyama S. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. /Okuyama S., Chaki S., Kawashima N. et al. // J. Pharmacol. Exp. Ther. 1999. V. 289. P.926–935.
Olds J. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. /Olds J, Milner P. // J Comp Physiol Psychol 1954; 47:419–427. [PubMed: 13233369]
Olds J. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. /Olds J., Milner P. // J Comp Physiol Psychol. 1954; 47:419–27. []
Olszewski, P.K. Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. /Olszewski, P.K., Grace, M.K., Billington, C.J., Levine, A.S. // Peptides 24 (6) - 2003a –
Olszewski, P.K. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. /Olszewski, P.K., Li, D.H., Grace, M.K., Billington, C.J., Kotz, C.M., Levine, A.S. // Peptides 24 (4) - 2003b – Р.597–602.
Patterson Z.R. Altered metabolic and neurochemical responses to chronic unpredictable stressors in ghrelin receptor-deficient mice. /Patterson Z.R., Ducharme R, Anisman H, Abizaid A. // Eur J Neurosci. 2010; 32:632–639. [PubMed]
Perello M. Functional implications of limited leptin receptor and ghrelin receptor co-expression in the brain. / Perello M, Scott MM, Sakata I, Lee CE, Chuang JC, et al. // J Comp Neurol 2011 [PMC free article] [PubMed]
Perello M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner /Perello M., Sakata I., Birnbaum S., Chuang J.C., Osborne-Lawrence S., Rovinsky, S.A., Woloszyn, J., Yanagisawa, M., Lutter M., Zigman J.M. // Biol. Psychiat. 2010. V. 67, №9. P. 880–886.
Perello, M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. /Perello, M., Sakata, I., Birnbaum, S., Chuang, J.C., Osborne-Lawrence, S., Rovinsky, S.A., Woloszyn, J., Yanagisawa, M., Lutter, M., Zigman, J.M., 2010. // BiologicalPsychiatry 67 (9), 880–886.
Perrin M.H. Cloning and functional expression of a rat brain corticotrophin releasing factor (CRF) receptor. /Perrin M.H., Donaldson C.J., Chen R. et al. // Endocrinology. 1993. V. 133. P.3058–3061.
Pettit H.O. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. /Pettit H.O., Ettenberg A., Bloom F.E., Koob G.F. // Psychopharmacology 1984;84:167–173.
Peyron, C. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. /C. Peyron, J. Faraco, W. Rogers et al. // Natural Medicine. – 2000 – Vol.6. – P.991–997.
Peyron, C. Neurons containing hypocretin (orexin) project to multiple neuronal systems. /C. Peyron, D. K. Tighe, A. N. Van den Pol et al. // J. Neurosci. – 1998 – Vol.18. – P.9996–10015.
Piazza P.V. The role of stress in drug self-administration. /Piazza P.V., Le Moal M. // Trends Pharmacol. Sci. 1998. V. 19. P.67–74.
Potter E. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. /Potter E., Sutton S., Donaldson C. et al. // Proc. Natl. Acad. Sci. USA. 1994. V. 91. P.8777–8781.
Price D.D. Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv 2002; 2:392–403. [PubMed: 14993415]
Quarta, D. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. /Quarta, D., Di Francesco, C., Melotto, S., Mangiarini, L., Heidbreder, C., Hedou, G. // NeurochemistryInternational 54 (2) – 2009 – Р.89–94.
Rassnick S. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. /Rassnick S, Heinrichs SC, Britton KT, Koob GF. // Brain Res 1993a; 605:25–32. [PubMed: 8467387]
Reyes T.M. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. /Reyes T.M., Walker J.R., DeCino C., Hogenesch J.B., Sawchenko P.E. // J Neurosci. 2003; 23:5607–16. []
Robinson, T.E. The neural basis of drug craving – an incentivesensitization theory of addiction. /Robinson, T.E., Berridge, K.C. // Brain Research Reviews 18 (3) – 1993 – Р.247–291.
Rosin, D. L. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. /D. L. Rosin, M C. Weston, C. P. Sevigny et al. // J. Comp. Neurol.
– 2003 - Vol.465, - P.593–603.